ArQule Aktie

4,935 $ +1,13% +0,055 $
In Euro: 4,2586 € | 19:03 Uhr Nasdaq | Mehr Kurse »
WKN: 903396
ISIN: US04269E1073
US-Symbol: ARQL
Typ: Aktie

Performance ArQule Aktie

  
1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 5,51 $ 3,39 $ 2,43 $ 1,65 $ 1,14 $ 1,74 $
Änderung -10,46% +45,54% +103,04% +199,02% +332,80% +183,56%

Forum zur ArQule Aktie

  
Nobsy11: ...
17.04.18
" Under the terms of the agreement, ArQule grants Basilea rights to research, develop, manufacture and exclusively commercialize derazantinib worldwide, excluding the People's Republic of China, Taiwan, Hong Kong and Macau. Basilea will make an upfront payment to ...
Abrafax: Phase 1 Ergebnisse ARQ-501 am 29.09.04
26.09.04
Phase 1 results for ARQ-501 will be presented at AACR-​NCI-EORTC meeting in Geneva and at the same time at UBS Global Life Sciences, NY 29.Sep.04 08.00 EST. 05.Oct.04 ArQule's Analyst Day What's Next- Cancer Therapeutics in the 21st Century übrigens: ARQ-501 ...

Analysen

  
Kaufen Halten Verkaufen
Analysten 0 0 0
Markt-Lotsen 0 0 0

ArQule Aktie & Unternehmen

  
Branche Pharmazie
Herkunft USA
Website www.arqule.com
Indizes/Listen NASDAQ
Aktienanzahl 87,1 Mio. (Stand: 28.05.18)
Marktkap. 436,1 Mio. $

Dividenden & Splits

  
03.10.12 Split 1:2 Berlin
02.10.12 Split 1:2 Frankfurt, München, Stuttgart

Ähnliche Aktien

  
Name
last
change_rel
 
Palatin Technologies 0,791 € -1,49%
Albireo Pharma 29,00 € +1,08%
Cannabis Science 0,055 € +7,84%
Gilead Sciences 61,49 € +0,74%
Maricann Group 1,21 € -2,42%